Adenosine-to-inosine RNA editing contributes to type I interferon responses in systemic sclerosis-Reference-Cited by-同舟云学术

Adenosine-to-inosine RNA editing contributes to type I interferon responses in systemic sclerosis

Published:2021-12 Issue: Volume:125 Page:102755
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Vlachogiannis Nikolaos I.^ORCID,Tual-Chalot Simon,Zormpas Eleftherios^ORCID,Bonini Francesca,Ntouros Panagiotis A.,Pappa Maria,Bournia Vasiliki-Kalliopi^ORCID,Tektonidou Maria G.^ORCID,Souliotis Vassilis L.^ORCID,Mavragani Clio P.,Stamatelopoulos Kimon,Gatsiou Aikaterini^ORCID,Sfikakis Petros P.,Stellos Konstantinos

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference70 articles.

1. Scleroderma;Gabrielli;N. Engl. J. Med.,2009

2. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway;Higgs;Ann. Rheum. Dis.,2011

3. Systemic sclerosis and lupus: points in an interferon-mediated continuum;Assassi;Arthritis Rheum.,2010

4. Integrative analysis reveals a molecular stratification of systemic autoimmune diseases;Barturen;Arthritis Rheum.,2021

5. A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis;Farina;Arthritis Rheum.,2010

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrative Transcriptomic Analysis of Peripheral Blood Monocytes in Systemic Sclerosis and Shared Pathogenic Pathways in Autoimmune Diseases;Archives of Medical Research;2025-01

2. RNA editing in response to COVID-19 vaccines: unveiling dynamic epigenetic regulation of host immunity;Frontiers in Immunology;2024-09-06

3. Writers, readers, and erasers RNA modifications and drug resistance in cancer;Molecular Cancer;2024-08-30

4. Ro60—Roles in RNA Processing, Inflammation, and Rheumatic Autoimmune Diseases;International Journal of Molecular Sciences;2024-07-14

5. RNA editing and immune control: from mechanism to therapy;Current Opinion in Genetics & Development;2024-06